🕒 Monday 1 June 2026 Mon, 1 June 2026

MFF Capital Investments’ May update shows a modest fall in net tangible assets per share and outlines a cautious yet optimistic portfolio stance amid geopolitical tensions and technological advances.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.

Intelligent Monitoring Group (ASX:IMB) has finalized its A$37 million purchase of Wormald NZ and Red Wolf, expanding its New Zealand footprint and projecting a 20.9% accretion in earnings per share.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

ReadyTech Holdings has dismissed an unsolicited acquisition proposal valuing the company at $2.00 per share, calling it undervalued and unworkable. The offer includes a parallel off-market bid at $1.75 per share with a 50.1% minimum acceptance condition.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Magnum Mining has advanced its auger drilling campaign at the Piracanjuba North Target, completing 161 holes over 7.4 km² and preparing for key Exploration Target and JORC Resource milestones later this year.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.

ASF Group has divested its non-core coking coal subsidiary for A$3.08 million, aiming to refocus capital towards growth and working capital enhancement.

Strata Minerals has secured a binding agreement with BML Ventures to fund and manage mining at its Zelica Gold Project, paving a capital-light path to production and profit sharing.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.

European Resources has identified six fresh passive seismic anomalies outside prior survey bounds at its Korsnäs rare earth project, prompting an exploration area increase and ongoing survey phases.

Bounty Oil & Gas NL has locked in A$4.5 million from a heavily oversubscribed share placement, with proceeds earmarked for drilling, facility upgrades, and exploration across its Australian assets.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

ARC Funds Limited has secured $600,000 through a share placement priced at a 33% premium to its last traded price, aiming to strengthen its working capital and support growth initiatives.

Turnstone Resources has exercised its option to acquire the Glava 100 copper-gold permit in Sweden, broadening its critical minerals footprint to seven licences across 100km2. The move sets the stage for drilling in H2 2026, pending regulatory approvals.

Regener8 Resources has completed its acquisition of the Srebrenica North polymetallic project in Bosnia and Herzegovina and is mobilising initial exploration activities to target drill-ready prospects.

FortifAI has appointed Kelly Herrell, a seasoned Silicon Valley CEO with a track record of scaling infrastructure tech companies to IPO and acquisition, as its new CEO. Herrell’s leadership aims to accelerate commercialisation of FortifAI’s AI Data Plane technology through its Nol8 subsidiary.

Raiz Invest announces a leadership change with Brendan Malone stepping down as CEO and Craig Keary taking over, signalling a new chapter for the fintech amid steady growth.

Memphasys has inked its first exclusive commercialization agreement in South-East Asia with TMSC Vietnam, targeting the fast-growing Vietnamese IVF sector with its Felix™ sperm separation system. The two-year contract, valued at A$530,000, hinges on regulatory approval expected by August 2026.

Alice Queen Limited has pushed back the closing date of its $5.77 million rights issue to 12 June 2026, giving shareholders more time to subscribe at 0.9 cents per share. The extension reflects the company's effort to maximise shareholder involvement ahead of the planned capital raise completion.